Charles Bonnet Syndrome: Successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors

Journal of Psychopharmacology

Volumn 21, Issue 5, 2007, Pages 553-555

  Lang, Undine E ^a   Stogowski, Dariusz ^a   Schulze, Doreen ^a   Domula, Markus ^a   Schmidt, Eckart ^a   Gallinat, Jüergen ^b   Tugtekin, Sems Malte ^c   Felber, Werner ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c University Heart Center Dresden   (Germany)

Author keywords

CBS; Charles Bonnet Syndrome; Epileptic; Escitalopram; Hallucinations; Serotonin; SSRI; Venlafaxine

Indexed keywords

CITALOPRAM; DULOXETINE; MILNACIPRAN; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

AGED; ARTICLE; CASE REPORT; CHARLES BONNET SYNDROME; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; FEMALE; HOSPITAL ADMISSION; HUMAN; MINI MENTAL STATE EXAMINATION; PATHOGENESIS; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VERBAL BEHAVIOR; VISUAL ACUITY; VISUAL HALLUCINATION; VISUAL IMPAIRMENT;

AGED; COGNITION; CYCLOHEXANOLS; EYE DISEASES; FEMALE; HALLUCINATIONS; HUMANS; SEROTONIN UPTAKE INHIBITORS; SYNDROME; TREATMENT OUTCOME; VISION DISORDERS;

EID: 34547117873     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106075275     Document Type: Article

References (19)

1. El Mansari M., Sanchez C., Chouvet G., Renaud B., Haddjeri N. (2005) Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology 30: 1269 - 1277
2. Ffytche D.H., Howard R.J., Brammer M.J., David A., Woodruff P., Williams S. (1998) The anatomy of conscious vision: an fMRI study of visual hallucinations. Nat Neurosci 1: 738 - 742
3. Frazer A. (2001) Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies. J Clin Psychiatry 12: 16 - 23
4. Hetzel G., Moeller O., Erfurth A., Michael N., Rothermundt M., Arolt V., Evers S. (2004) The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients. Pharmacopsychiatry 37: 200 - 205
5. Hori H., Terao T., Shiraishi Y. (2000) Treatment of Charles Bonnet Syndrome with valproate. Int Clin Psychopharmacol 15: 117 - 119
6. Kemp A.H., Gray M.A., Silberstein R.B., Armstrong S.M., Nathan P.J. (2004) Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans. Neuroimage 22: 1084 - 1096
7. Lorberboym M., Lampl Y., Gilad R., Sadeh M. (2002) Tc-99m ethylcysteinate dimer brain SPECT perfusion imaging in ictal nonepileptic visual hallucinations. Clin Nucl Med 27: 87 - 91
8. Maeda K., Shirayama Y., Nukina S., Yoshioka S., Kawahara R. (2003) Charles Bonnet syndrome with visual hallucinations of childhood experience: successful treatment of 1 patient with risperidone. J Clin Psychiatry 64: 1131 - 1132
9. Menon G.J. (2005) Complex visual hallucinations in the visually impaired. Arch Ophthalmol 123: 349 - 355
10. Menon G.J., Rahman I., Menon S.J., Dutton G.N. (2003) Complex visual hallucinations in the visually impaired: the Charles Bonnet syndrome. Surv Ophthalmol 48: 58 - 72
11. Oliveri M., Calvo G. (2003) Increased visual cortical excitability in ecstasy users: a transcranial magnetic stimulation study. J Neurol Neurosurg Psychiatry 74: 1136 - 1138
12. Paulig M., Mentrup H. (2001) Charles Bonnet syndrome: complete remission of complex visual hallucinations treated by gabapentin. J Neurol Neurosurg Psychiatry 70: 813 - 814
13. Pliskin N.H., Kiolbasa T.A., Towle V.L., Pankow L., Ernest J.T., Noronha A., Luchins D.J. (1996) Charles Bonnet syndrome: an early marker for dementia? J Am Geriatr Soc 44: 1055 - 1061
14. Qu Y., Eysel U.T., Vandesande F., Arckens L. (2000) Effect of partial sensory deprivation on monoaminergic neuromodulators in striate cortex of adult cat. Neuroscience 101: 863 - 868
15. Ranen N.G., Pasternak R.E., Rovner B.W. (1999) Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome. Am J Geriatr Psychiatry 7: 264 - 266
16. Rovner B.W. (2006) The Charles Bonnet syndrome: a review of recent research. Curr Opin Ophthalmol 17: 275 - 277
17. Seeburg D.P., Liu X., Chen C. (2004) Frequency-dependent modulation of retinogeniculate transmission by serotonin. J Neurosci 24: 10950 - 10962
18. Stahl S.M., Grady M.M., Moret C., Briley M. (2005) SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10: 732 - 747
19. Tan C S., Sabel B A., Eong K G. (2006) Charles Bonnet syndrome (visual hallucinations) following enucleation. Eye [Epub ahead of print]